Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial Results by mparnell | Nov 3, 2016 | Portfolio News
Corcept Therapeutics Announces Third Quarter 2016 Financial Results and Provides Corporate Update by mparnell | Nov 1, 2016 | Portfolio News
Velicept Therapeutics, Inc. Names Clarence Young, M.D., Chief Medical Officer by mparnell | Oct 27, 2016 | Portfolio News
Encore Dermatology, Inc. Announces Launch of HylatopicPlus® Lotion by mparnell | Oct 13, 2016 | Portfolio News
Bempedoic Acid Global Phase 3 Clinical Program to Include Patients on Any Statin at Any Dose by mparnell | Oct 13, 2016 | Portfolio News